CompletedNot Applicable

Biobehavioral Correlates of Cancer-related Cognitive Dysfunction and Its Co-occurring Symptoms

United States682 participantsStarted 2020-11-16

Plain-language summary

This descriptive, cross-sectional study will evaulate and fully characterize factors associated with cognitive dysfunction in Breast Cancer (BCS) and Colorectal Cancer (CRC) survivors that have cognitive concerns, and factors associated with psychoneurological symptom cluster in BCS and CRC survivors.

Who can participate

Age range21 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Female BCS
✓. ≥ 21 years of age and older
✓. Ability to provide written consent and HIPAA authorization
✓. ≥6 months post-adjuvant therapy and neo-adjuvant therapy for early stage (Stage I-IIIA) breast cancer.
✓. Identify cognitive concerns (select yes)
✓. Male or female CRC survivors
✓. Ability to provide written consent and HIPAA authorization
✓. ≥ 21 years of age and older

Exclusion criteria

✕. Report metastatic breast or colorectal cancer (Stage IV) at time of consenting.
✕. Unable to read and understand English to complete survey questionnaires.

What they're measuring

Subjective Cognitive Dysfunction

Timeframe: greater than or equal to 6 months post cancer treatment

Trial details

NCT IDNCT04611620

SponsorIndiana University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-05-12

View on ClinicalTrials.gov More Survivorship trials